According to Bloomberg Businessweek, defendant Johnson & Johnson agreed to pay approximately $600,000 to resolve three cases filed in Nevada state court.
New York, NY (PRWEB) August 22, 2012
DePuy ASR hip recall lawsuits, Rundle v. DePuy Orthopaedics Inc., A-11-636272, Clark County District Court (Las Vegas), scheduled for trial in December 2012 have settled, Bernstein Liebhard LLP reports.* According to Bloomberg Businessweek, defendant Johnson & Johnson agreed to pay approximately $600,000 to resolve three cases filed in Nevada state court. Claims brought by Annelise Rundle, Martha Bender and Katherine Guy had been consolidated and scheduled to go to trial on December 3, 2012. Each of the plaintiffs alleged that they had received a recalled ASR hip implant, which subsequently failed, requiring them to undergo revision surgery to have the defective device removed. Although details of the settlement agreement have not been disclosed, Bloomberg reports that the company will pay around $200,000 a case. Johnson & Johnson is currently defending approximately 6,000 lawsuits stemming from the August 2010 ASR hip recall. Given that the initial DePuy ASR hip recall lawsuits have settled, the next trial date is scheduled for January 2013 in Maryland state court. The first federal DePuy ASR hip recall lawsuit trial is scheduled to begin on May 6, 2013 with the second trial set for July 8, 2013.
Since the DePuy ASR hip recall was issued, Bernstein Liebhard LLP has carefully monitored developments and reports on the safety of metal hip implants. In addition, the Firm is representing clients who were implanted with the recalled devices in In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), which is currently underway in the U.S. District Court for the Northern District of Ohio.
Potential Costs Associated With The DePuy ASR Hip Recall Lawsuits
As reported by Bloomberg Businessweek, in January 2012, Johnson & Johnson said that it had spent about $800 million on the ASR hip recall over the past two years. While the company declined to estimate its product liability costs, Eric Gordon, a business professor at the University of Michigan, told Bloomberg that “it may cost the drugmaker as much as $2 billion to resolve all litigation over DePuy’s ASR hips.” He added, “They’re looking at a giant number before it’s done because there are a giant number of cases.”
DePuy ASR hip recall lawsuits continue to be filed by Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices, on behalf of individuals who received DePuy ASR hip implants. Those who have suffered damages as a result of being implanted with a metal-on-metal hip may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. Learn more by watching this DePuy ASR hip recall video, or by visiting our website, http://www.consumerinjurylawyers.com/DePuy/. For more information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.